Tavlesse الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

tavlesse

instituto grifols s.a. - Динатриевая fostamatinib - trombocitopenija - druge sistemske кровоостанавливающие - tavlesse je indiciran za liječenje kronične imunološki тромбоцитопении (ihs) u odraslih bolesnika, vatrostalne standardnim tretmanima na druge metode liječenja.

OMNITROPE 10 mg/1.5 mL rastvor za injekciju u patroni البوسنة والهرسك - الكرواتية - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

omnitrope 10 mg/1.5 ml rastvor za injekciju u patroni

sandoz d.o.o. - somatropin - rastvor za injekciju u patroni - 10 mg/1.5 ml - 1,5 ml rastvor za injekciju u patroni sadrži: 10 mg somatropina

Jyseleca الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

jyseleca

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

NORDITROPIN NORDIFLEX 5 mg/1.5 mL rastvor za injekciju u napunjenom penu البوسنة والهرسك - الكرواتية - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

norditropin nordiflex 5 mg/1.5 ml rastvor za injekciju u napunjenom penu

novo nordisk pharma d.o.o. - somatropin - rastvor za injekciju u napunjenom penu - 5 mg/1.5 ml - 1 ml rastvora za injekciju u napunjenom penu sadrži 3,3 mg somatropina

NORDITROPIN NORDIFLEX 10 mg/1.5 mL rastvor za injekciju u napunjenom penu البوسنة والهرسك - الكرواتية - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

norditropin nordiflex 10 mg/1.5 ml rastvor za injekciju u napunjenom penu

novo nordisk pharma d.o.o. - somatropin - rastvor za injekciju u napunjenom penu - 10 mg/1.5 ml - jedan ml rastvora sadrži 6,7 mg somatropina

Nyxthracis (previously Obiltoxaximab SFL) الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imuni serumi i homologna, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Spikevax (previously COVID-19 Vaccine Moderna) الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Calquence الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - leukemija, limfocitna, kronična, b-stanica - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - cjepiva - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Efmody الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

efmody

diurnal europe b.v. - hidrokortizon - adrenal hyperplasia, congenital - kortikosteroidi za sistemsku upotrebu - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.